FTC

Watson Pharmaceuticals and Arrow Group Receive FTC Second Request

MORRISTOWN, N.J., Aug. 6 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI ), a leading specialty pharmaceutical company, today announced that it has received a request for additional information from the Federal Trade Commission ("FTC") in connection with Watson's...

CDYNE XML Web Services Help Organizations Comply with FTC Red Flags Rule

Web-Based Fraud Prevention Tools Can Reduce Medical Identity Theft CHESAPEAKE, Va., July 1 /PRNewswire/ -- CDYNE Corporation , a leading provider of data enhancement, verification, and communication Web services, announced today that it is ready to assist health care organizations prepare ...

GPhA Statement on FTC Report on 'Follow-on Biologic Drug Competition'

ARLINGTON, Va., June 10 /PRNewswire/ -- The Generic Pharmaceutical Association (GPhA) released the following statement today from GPhA President and CEO Kathleen Jaeger regarding publication of the Federal Trade Commission (FTC) Report on "Follow-on Biologic Drug Competition." "Today's repor...

GPhA Statement on FTC Roundtable on Biogenerics

ARLINGTON, Va., Nov. 21 /PRNewswire-USNewswire/ -- The Generic Pharmaceutical Association (GPhA) released the following statement today from GPhA President and CEO Kathleen Jaeger regarding the Federal Trade Commission (FTC) roundtable on "Emerging Health Care Competition and Consumer Issues." ...

Teva and Barr Receive FTC Request for Additional Information

JERUSALEM and MONTVALE, N.J., Sept. 3 /PRNewswire-FirstCall/ -- Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA ) and Barr Pharmaceuticals, Inc. (NYSE: BRL ) announced today that, as expected, each party has received a request for additional information (commonly referred to as a "second r...

Sun Pharma Announces U.S. FTC Clearance for Taro Tender Offer

MUMBAI, India, Aug. 13 /PRNewswire/ -- Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUN PHARMA, BSE: 524715) today announced that on August 13, 2008, the U.S. Federal Trade Commission (FTC) granted early termination of the antitrust waiting period under the Har...

Former FTC Attorney Christine White Joins Crowell & Moring's Health Care and Antitrust Groups

WASHINGTON, Jan. 30 /PRNewswire-USNewswire/ -- Crowell & Moring LLP is pleased to announce the addition of partner Christine L. White to its New York office as a member of the firm's Antitrust and Health Care groups. White joins from Bingham McCutchen LLP, where she helped found and co-chair t...

Tanning Beds Get Highest Carcinogen Rating

...istration (FDA) and the U.S. Federal Trade Commission (FTC) each regulate tanning beds and sunlamps. The FDA regulates labeling of the devices and the ftc regulates advertising claims about the devices. The FDA currently requires tanning salons to direct all customers to wear protective eye goggles an...

Caraco Pharmaceutical Laboratories, Ltd. Enters Into Asset Purchase Agreement with Forest Laboratories, Inc. to Settle Lexapro(R) (escitalopram oxalate) ANDA Patent Litigation

...ner than 40 days after the signing, which the parties hope will provide the ftc and DOJ with sufficient time to review the transaction. As the transaction must be submitted to the ftc and DOJ, there is a possibility that the transaction may need to either be ...

Federal Trade Commission Reports: Authorized Generics, During the 180-day Exclusivity Period, Benefit Consumers and the American Healthcare System

...ption drug marketplace. Prasco commends the ftc in its approach. "This Interim Report is the resu...rington. According to the Interim Report, the ftc found that: "...[C]onsumers ben...xclusivity period when an AG enters the market..." ftc report Authorized Generics: An Interim Report - Ju...

FTC in Biological Technology

Immucor Responding to FTC Inquiry

NORCROSS, Ga., Oct. 26 /PRNewswire-FirstCall/ -- Immucor, Inc. (Nasdaq/NM: BLUD), a global provider of automated instrument-reagent systems to the blood transfusion industry, announced today that on October 12, 2007, the company received a letter from the Federal Trade Commission ("FTC") reque...

U.S. Federal Trade Commission to Challenge Thoratec's Proposed Acquisition of HeartWare International

... manufactures miniaturized implantable heart pumps, announced today that the United States Federal Trade Commission ("FTC") has informed them that the ftc will file a complaint in U.S. Federal District Court to challenge Thoratec's proposed acquisition of HeartWare International. Thoratec and Hear...

GPhA Says BIO Cries Wolf on Senate Biogenerics Proposal

...es in the face of the recent Federal Trade Commission (FTC) report that such long periods of exclusivity are NOT needed to spark innovation. In fact, ftc suggested that because of their extremely robust intellectual property protection in this sector, 'no' to little market exclusivity is required. ...

CSL Limited and Talecris Biotherapeutics Agree to Terminate Merger Agreement

...inted that the U.S. Federal Trade Commission (FTC) resolved to block the transaction. As we have previously stated we fundamentally disagree with the ftc case and matters included in their complaint. Although we continue to believe in the many customer benefits and significant financial synergies that ...

Kibow Biotech, Inc. Launches Breakthrough Probiotic Dietary Supplement for Kidney Health in USA and Canada

... though Kibow Biotics is a non-prescription product. Dr. Natarajan Ranganathan, Interim CEO and Senior VP (R&D), stated, "As per U.S. FDA and ftc regulations, we cannot refer directly or indirectly to our product formulation with words like 'disease,' 'drug,' 'therapy,' 'prevent,' 'cure,' 'delay...

Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion

...ent agreement between Shire and Barr. On June 22, 2007 the Company received a civil investigative demand requesting that it provide information to the ftc relating to its settlement with Barr and its earlier settlement with Impax Laboratories, Inc. The Company is cooperating fully with this investigation...

Immucor Announces Fiscal Year 2009 Revenue and Earnings Guidance

...st rates; fluctuations in foreign currency conversion rates; the outcome of any legal claims known or unknown; the outcome of the previously-announced ftc investigation into certain past acquisitions; disruptions to the supply of key raw materials; the unexpected application of different accounting rules...

Life Sciences Industry Reaches Crossroad Say Noted Pillsbury Attorneys

...tors, including the Federal Trade Commission and the Department of Justice, are shining light on the industry. Among other investigations, the ftc is exploring the competitive implications of deals in which brand-name pharmaceutical companies allegedly collaborated with their generic drug...

Immucor To Acquire BioArray Solutions Ltd.

...ot limited to the following: the possibility that Hart-Scott-Rodino pre-merger notification clearance may be denied in light of the recently-announced ftc investigation of past Company acquisitions; the ability of the Company to successfully develop an automated platform for BioArray's transfusion genoty...

Cephalon Statement on Federal Trade Commission Action Regarding PROVIGIL Patent Settlements

...ment and capabilities; legal matters, including the ultimate outcome of the ftc litigation or the amount of time it will take for the ftc litigation to be resolved; market prospects for its products; sales, adjust...

FTC in Biological Dictionary

FIFRA

...Save up to 80%, buy or rent. New and used books like FIFRA Federal Insecticide Fungicide and Rodenticide Act Basic Practice... ... that EPA and ftc do little to enforce FIFRA laws on advertising putting the public at risk. ... FIFRA also authorizes EPA to take enforcement action ... Onlin...